Investor Relations

Positron is establishing a unique market position by integrating our cost-effective Attrius® PET scanner, technical and clinical expertise and innovative financing solutions to its customers.  The demand for cardiac PET is now greater than ever before. We believe Positron's offerings and pro-business approach will bring substantial advantages in accelerating the adoption of cardiac PET and growth of the nuclear cardiology industry.

For over 30 years Positron has been the industry’s authority in the business of cardiac PET.  Positron has built a strong business model capable of meeting the cardiac PET market's current and future demands.  Our continued efforts will secure a profitable future for Positron investors and strengthen our position as the leader in our field. Positron has significant potential earnings power with projected exponential revenue growth and we believe Positron will play a major role in the landscape changes of the nuclear cardiology industry over the next decade.